Literature DB >> 25369458

Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma.

Amy S Feldman1, Yuan He, Martin L Moore, Marc B Hershenson, Tina V Hartert.   

Abstract

A first step in primary disease prevention is identifying common, modifiable risk factors that contribute to a significant proportion of disease development. Infant respiratory viral infection and childhood asthma are the most common acute and chronic diseases of childhood, respectively. Common clinical features and links between these diseases have long been recognized, with early-life respiratory syncytial virus (RSV) and rhinovirus (RV) lower respiratory tract infections (LRTIs) being strongly associated with increased asthma risk. However, there has long been debate over the role of these respiratory viruses in asthma inception. In this article, we systematically review the evidence linking early-life RSV and RV LRTIs with asthma inception and whether they could therefore be targets for primary prevention efforts.

Entities:  

Keywords:  RSV; RV; asthma; respiratory syncytial virus; rhinovirus

Mesh:

Substances:

Year:  2015        PMID: 25369458      PMCID: PMC4299628          DOI: 10.1164/rccm.201405-0901PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  121 in total

1.  Maternal smoking in pregnancy alters neonatal cytokine responses.

Authors:  P S Noakes; P G Holt; S L Prescott
Journal:  Allergy       Date:  2003-10       Impact factor: 13.146

Review 2.  Biology of lung dendritic cells at the origin of asthma.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Immunity       Date:  2009-09-18       Impact factor: 31.745

3.  Increased incidence of asthma in children of smoking mothers.

Authors:  F D Martinez; M Cline; B Burrows
Journal:  Pediatrics       Date:  1992-01       Impact factor: 7.124

4.  Interleukin-6, interleukin-8, interleukin-11, and interferon-gamma levels in nasopharyngeal aspirates from wheezing children with respiratory syncytial virus or influenza A virus infection.

Authors:  Jae-Won Oh; Ha-Baik Lee; Il-Kyu Park; Jung-Oak Kang
Journal:  Pediatr Allergy Immunol       Date:  2002-10       Impact factor: 6.377

5.  Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses.

Authors:  G P Rakes; E Arruda; J M Ingram; G E Hoover; J C Zambrano; F G Hayden; T A Platts-Mills; P W Heymann
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

6.  Interaction between asthma and lung function growth in early life.

Authors:  Hans Bisgaard; Signe M Jensen; Klaus Bønnelykke
Journal:  Am J Respir Crit Care Med       Date:  2012-03-29       Impact factor: 21.405

7.  Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness.

Authors:  Dina Schneider; Jun Y Hong; Antonia P Popova; Emily R Bowman; Marisa J Linn; Alan M McLean; Ying Zhao; Joanne Sonstein; J Kelley Bentley; Jason B Weinberg; Nicholas W Lukacs; Jeffrey L Curtis; Uma S Sajjan; Marc B Hershenson
Journal:  J Immunol       Date:  2012-02-13       Impact factor: 5.422

8.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.

Authors:  R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

9.  Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression.

Authors:  C L Ordoñez; R Khashayar; H H Wong; R Ferrando; R Wu; D M Hyde; J A Hotchkiss; Y Zhang; A Novikov; G Dolganov; J V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

10.  Rhinovirus-induced wheezing in infancy--the first sign of childhood asthma?

Authors:  Anne Kotaniemi-Syrjänen; Raija Vainionpää; Tiina M Reijonen; Matti Waris; Kaj Korhonen; Matti Korppi
Journal:  J Allergy Clin Immunol       Date:  2003-01       Impact factor: 10.793

View more
  84 in total

1.  Reply: Toward Primary Prevention of Asthma: Role of Corticosteroids for the First Rhinovirus Wheeze.

Authors:  Tina Hartert; Marc Hershenson
Journal:  Am J Respir Crit Care Med       Date:  2015-10-15       Impact factor: 21.405

Review 2.  Lung functional development and asthma trajectories.

Authors:  Fabienne Decrue; Olga Gorlanova; Jakob Usemann; Urs Frey
Journal:  Semin Immunopathol       Date:  2020-01-27       Impact factor: 9.623

Review 3.  Respiratory Syncytial Virus Infection: An Illness for All Ages.

Authors:  Edward E Walsh
Journal:  Clin Chest Med       Date:  2016-12-27       Impact factor: 2.878

4.  Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy.

Authors:  Christian Rosas-Salazar; Meghan H Shilts; Andrey Tovchigrechko; Seth Schobel; James D Chappell; Emma K Larkin; Jyoti Shankar; Shibu Yooseph; Karen E Nelson; Rebecca A Halpin; Martin L Moore; Larry J Anderson; R Stokes Peebles; Suman R Das; Tina V Hartert
Journal:  J Infect Dis       Date:  2016-12-15       Impact factor: 5.226

5.  Genes associated with RSV lower respiratory tract infection and asthma: the application of genetic epidemiological methods to understand causality.

Authors:  Emma K Larkin; Tina V Hartert
Journal:  Future Virol       Date:  2015-07       Impact factor: 1.831

6.  Nasopharyngeal Microbiome in Respiratory Syncytial Virus Resembles Profile Associated with Increased Childhood Asthma Risk.

Authors:  Christian Rosas-Salazar; Meghan H Shilts; Andrey Tovchigrechko; James D Chappell; Emma K Larkin; Karen E Nelson; Martin L Moore; Larry J Anderson; Suman R Das; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2016-05-15       Impact factor: 21.405

7.  NK cells contribute to persistent airway inflammation and AHR during the later stage of RSV infection in mice.

Authors:  Xiaoru Long; Jun Xie; Keting Zhao; Wei Li; Wei Tang; Sisi Chen; Na Zang; Luo Ren; Yu Deng; Xiaohong Xie; Lijia Wang; Zhou Fu; Enmei Liu
Journal:  Med Microbiol Immunol       Date:  2016-06-21       Impact factor: 3.402

8.  Prolonged viral replication and longitudinal viral dynamic differences among respiratory syncytial virus infected infants.

Authors:  Monica E Brint; Joshua M Hughes; Aditya Shah; Chelsea R Miller; Lisa G Harrison; Elizabeth A Meals; Jacqueline Blanch; Charlotte R Thompson; Stephania A Cormier; John P DeVincenzo
Journal:  Pediatr Res       Date:  2017-08-09       Impact factor: 3.756

9.  Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines.

Authors:  Lindsay Kim; Brian Rha; Jon S Abramson; Larry J Anderson; Carrie L Byington; Grace L Chen; John DeVincenzo; Kathryn M Edwards; Janet A Englund; Ann R Falsey; Marie R Griffin; Ruth A Karron; Karen G Martin; H Cody Meissner; Flor M Munoz; Andrew T Pavia; Pedro A Piedra; William Schaffner; Eric A F Simões; Rosalyn Singleton; H Keipp Talbot; Edward E Walsh; Jane R Zucker; Susan I Gerber
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079

10.  A Review of the CD4+ T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population.

Authors:  Ravi S Misra
Journal:  EC Microbiol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.